Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy

PURPOSE: COVID-19 associated pulmonary aspergillosis (CAPA) is associated with increased morbidity and mortality in ICU patients. We investigated the incidence of, risk factors for and potential benefit of a pre-emptive screening strategy for CAPA in ICUs in the Netherlands/Belgium during immunosupp...

Descripción completa

Detalles Bibliográficos
Autores principales: van Grootveld, Rebecca, van der Beek, Martha T., Janssen, Nico A.F., Ergün, Mehmet, van Dijk, Karin, Bethlehem, Carina, Stads, Susanne, van Paassen, Judith, Heunks, Leo M.A., Bouman, Catherine S.C., Reijers, Monique H.E., Brüggeman, Roger J., van de Veerdonk, Frank L., van Bree, Sjoerd H.W., van den Berg, Charlotte H.S.B., Kuindersma, Marnix, Wauters, Joost, Beishuizen, Albertus, Verweij, Paul E., Schouten, Jeroen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934852/
https://www.ncbi.nlm.nih.gov/pubmed/36801598
http://dx.doi.org/10.1016/j.jcrc.2023.154272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934852/
https://www.ncbi.nlm.nih.gov/pubmed/36801598
http://dx.doi.org/10.1016/j.jcrc.2023.154272

Ejemplares similares